Viewing Study NCT01423851


Ignite Creation Date: 2025-12-24 @ 11:55 PM
Ignite Modification Date: 2026-01-10 @ 2:09 PM
Study NCT ID: NCT01423851
Status: COMPLETED
Last Update Posted: 2022-03-09
First Post: 2011-08-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
Sponsor: NS Pharma, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NS-018-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators